FDA Clears IND for iNKT Cells to Treat COVID-19 Patients
Go back to FDA Clears IND for iNKT Cells to Treat COVID-19 Patients| AGENUS (NASDAQ: AGEN) | Delayed: 6.94 +0.05 (0.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.89 | 52 Week High | $7.49 | |||
| Open | $6.93 | 52 Week Low | $2.61 | |||
| Day High | $7.02 | P/E | N/A | |||
| Day Low | $6.70 | EPS | $-1.10 | |||
| Volume | 790,460 | |||||
